Premier Path Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.17M Buy
21,802
+2,887
+15% +$399K 0.37% 68
2026
Q2
$2.43M Buy
18,915
+1,338
+8% +$157K 0.28% 87
2026
Q1
$2.11M Buy
17,577
+3,748
+27% +$433K 0.28% 85
2025
Q4
$1.46M Buy
13,829
+2,138
+18% +$201K 0.19% 113
2025
Q3
$981K Buy
11,691
+2,527
+28% +$208K 0.13% 178
2025
Q2
$725K Sell
9,164
-2,962
-24% -$235K 0.1% 208
2025
Q1
$1.09M Sell
12,126
-598
-5% -$55.8K 0.17% 152
2024
Q4
$1.27M Sell
12,724
-2,012
-14% -$207K 0.19% 121
2024
Q3
$1.67M Sell
14,736
-785
-5% -$93.3K 0.26% 91
2024
Q2
$1.92M Buy
15,521
+1,178
+8% +$152K 0.33% 73
2024
Q1
$1.89M Buy
14,343
+8
+0.1% +$986 0.36% 73
2023
Q4
$1.56M Buy
+14,335
New +$1.49M 0.35% 64

Other funds holding MRK

Premier Path Wealth Partners's MRK Position: Q3 2026 in Review

Premier Path Wealth Partners increased its Merck (MRK) stake by 15% in Q3 2026, buying an estimated $399K and bringing the position to 21,802 shares worth $3.17M. The position accounts for 0.37% of the portfolio, ranked #68.

Premier Path Wealth Partners first reported a position in MRK in Q4 2023 and has held it in 12 quarters since. 3,938 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Premier Path Wealth Partners held 21,802 shares of Merck worth $3.17M as of Q3 2026.
  • Premier Path Wealth Partners bought 2,887 Merck shares in Q3 2026, an estimated $399K.
  • Merck made up 0.37% of Premier Path Wealth Partners's portfolio in Q3 2026, its #68 holding.
  • Premier Path Wealth Partners first reported a position in Merck in Q4 2023 and has held it in 12 quarters since.
  • 3,938 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Premier Path Wealth Partners's 13F filing for Q3 2026, filed 16 Oct 2026.